Académique Documents
Professionnel Documents
Culture Documents
Program: BSN2y2-3
Generic Brand Classicatio Actual dose Action Rationale Side effect Nursing
name n Considerati
on
Diazepa Valium central 2 mg, 5 mg, Most of these used to Shakiness and -Monitor for
m nervous 10 mg tablets; effects are treat anxiety Unsteady walk adverse
system 1 mg/mL, 5 thought to disorders, alc unsteadiness, reactions
agent; mg/mL, 5 result from a ohol trembling, -Monitor for
benzodiazep mg/5 mL oral facilitation of withdrawal or other therapeutic
ine solution; 5 the action of symptoms, or problems with effectiveness
anticonvulsa mg/mL gamma muscle muscle .
nt; injection; 2.5 aminobutyric spasms. control or Periodic CBC
anxiolytic mg, 5 mg, 10 acid (GABA), Diazepam is coordination and liver
mg, 15 mg, 20 an inhibitory sometimes function tests
mg rectal gel neurotransmi used with during
tter in the other prolonged
central medications therapy.
nervous to treat
system. seizures.
Phenytoi Dilantin Central 50 mg/mL ; 50 Decreases used to nausea, -Monitor
n nervous mg ; 100 mg ; the control vomiting, blood
System 30 mg ; 25 Likelihood of certain type constipation; levels.
agent; mg/mL ; 200 convulsions of seizures, tremors, Assess any
anticonvulsa mg ; 300 mg ; by and to treat slurred residual
nt; sodium reducing and prevent speech, loss of seizure
hydantoin Children from abnormal seizures that balance behavior.
6 months to 6 electrical may begin or Phenytoin is
years Vmax = discharges during or coordination; incompatible
12 mg/Kg/day within the after surgery rash; with dextrose
(10-13) brain. to the brain headache; containing
Children from or nervous confusion, solutions.
7 to 16 years system. dizziness, - Flush IV
Vmax = 9 Phenytoin is nervousness; with
mg/Kg/day (8- in a class of or.sleep saline before
20) medications problems and after
Children from called (insomnia).
6 months to anticonvulsan
16 years Km = ts. It works
4 mg/L (2-13) by
decreasing
abnormal
electrical
activity in the
brain.
Hydralazi Apresoli Antihyperte Children: 7.5 vasodilator Hydralazine headache, -Monitor
ne ne nsive, mg/kg/da that is also used anorexia, CBC,
Vasodilator y PO or works by after heart nausea, electrolytes,
200 mg/day relaxing valve vomiting, LE
PO, whichever the muscles replacement diarrhea, cell prep,
is less, or 3.5 in the blood and in the palpitations, and ANA titer
mg/kg/day IV vessels to treatment of tachycardia prior to and
or IM help them heart failure. (rapid periodically
dilate This Talk to your heartbeat), during
lowers doctor about and prolonged
blood the possible angina therapy.
pressure and risks of using pectoris
allows blood this (chest pain).
to flow more medication
easily for your
through condition.
the veins and
arteries
Penicillin Bicilllin Based upon Moderate Penicillin kills used to treat Hypersensitivi -Assess
G L-A Penicillins to severe Susceptible a wide ty patient
ability infections bacteria by variety reactions for previous
to execute Adult and specifically ofbacterial (rash, sensitivity
or child:IM inhibiting the infections. It urticaria, reaction to
destroy 600,000-1.2 transpeptidas may also be serum penicillins or
bacterium million units in e that used to sickness); cephalos
and 1 or 2 catalyzes the prevent local porins
effectivenes doses/day for final step in certain effects. -Obtain C&S
s 10 cell wall bacterial before
(ranging biosynthesis, infections beginning
from the cross- (such drug
limited to linking of as rheumatic therapy to
extensive), peptidoglyca fever). This identify if
they n. medication is correct
can be a long-acting -treatment
classified penicillin has
into antibiotic. It been
following works by initiated
four classes. stopping the Assess for
growth of allergic
bacteria. Reactions.
Norepin Lovarter adrenergic 1 mg/mL ; primarily May cause -Monitor
ephrine enol agonist, 8mg/250 mL- alpha- headache, intake
inotropic, D5% ; mediated anxiety, and output.
vasopressor 16mg/250mL- vasoconstricti arrhythmias, Norepin
D5% ; on= bradycardia, ephrine
4mg/250mL- increased BP respiratory reduces
D5% ; & difficulty, renal
4mg/250 mL- coronary ischemic bloodflow,
NaCl 0.9% ; blood flow. injury, or which may
8mg/250mL- beta extravasation cause
NaCl 0.9% ; 16 action=inotro at the infusion decreased
mg/250 mL- poic site. urine output
NaCl 0.9% ; stimulation initially.
4mg/500 mL- and -Avoid
D5% ; dilation of contact
16mcg/mL- coronary of drug with
NaCl 0.9% arteries iron salts,
alkalies, or
oxidizing
agents.
-Protect
solution from
light. Discard
solution
thats
discolored or
contains a
precipitate.
Metronid Flagyl Antibiotic, Patients Dose: It inhibits This Headache, -Give drug
azole Antibacterial Metronid azole nucleic antibiotic dizziness, with
, 500mg1 acid treats only ataxia, meals to
Amebicide, tab TID PO synthesis by certain vertigo, minimize GI
Antiprotozoa Minimum disrupting bacterial and incoordination, distress
l Dose: the DNA of parasitic insomnia, To treat
PO : 250mg microbial infections. It seizures, trichomoniasi
TID IV : 100mg cells will not work peripheral s,
/mL for neuropathy, give drug for
viral fatigue, 7 days
infections anorexia, instead
(such as nausea, of 2-g
common vomiting, single
cold, flu). diarrhea, GI dose Use
Using any upset, cramps only
antibiotic Dysuria, after
when it is not incontinence, T.vaginal
needed can darkening of is has been
cause it to the urine confirmed by
not work for Thrombophl wet smear
future ebitis (IV) -Tablets may
infections be
crushed for
pts.
with difficult
swallowing
-Do not
use
aluminium
needles or
hubs,
color will turn
orange/rust
Omepraz Prilosec gastrointesti 10 mg, 20 mg, An antisecret Duodenal and CNS: -Monitor
ole nal 40 mg ory gastric ulcer. Headache, Urinalysis for
agent; capsules compound Gastroesopha dizziness, hematuria
proton that is a geal reflux fatigue. and
pump gastric acid disease GI: proteinuria.
inhibitor pump including Diarrhea, Periodic liver
inhibitor. severe abdominal function tests
Suppresses erosive pain, nausea, with
gastric acid esophagitis mild transient prolonged
secretion by (4 to 8 wk increases in use.
inhibiting the treatment). liver function -Assess GI
H+, Long-term tests. system:
K+-ATPase treatment of Urogenital: bowel sounds
enzyme pathologic Hematuria, every 8hours,
system hypersecreto proteinuria. abdomen for
[the acid ry conditions Skin:Rash pain and
(proton such as swelling,
H+) pump] in Zollinger appetite loss
the - -Assess other
parietal cells. Ellison medications
syndrome, patient may
multiple be taking for
endocrine effectiveness
adenomas, and
and interactions
systemic
mastocytosis.
Pregabali Lyrica analgesics,a 100 mg three Binds to treated with Difficult or -Monitor for
n nticonv times a day calcium antidepressa Labored weight gain,
ulsants (300 mg/day) channels in nts, various breathing peripheral
Pharmacolo in patients CNS tissues anticonvulsan shortness of edema, and
gic: with creatinine which ts, opioids, breath S&S of heart
gammaamin clearance of at regulate and tightness in failure,
obutyric least neurotransmi cannabinoids, the chest especially
acid (GABA) 60mL/min. tter but in many with
analogues,n Begin dosing release. Does cases concurrent
onopioid at 50 mg three not treatment is thiazolidi
analgesics times a bind to opioid insufficient nedione
day (150 receptors and (e.g.,
mg/day). associated rosiglitazone)
The dose may with a range therapy.
be increased of side- -Lab tests:
to 300mg/day effects. Baseline and
within 1 week periodic
kidney
function
tests;
periodic
platelet
counts;
CPK if
rhabdom
yolysis is
suspected.
-Monitor
diabetics for
increased
incidences of
hypoglycemi
a
Furosemi Lasix electrolytic 20 mg, 40 mg, Rapid-acting blocking the CV:Postural -Observe
de and water 80 mg potent absorption of hypotension, patients
balance tablets; 10 sulfonamide sodium, dizziness with receiving
mg/mL, 40 loop chloride, and excessive parenteral
agent; loop
mg/5 mL oral diuretic and water from diuresis, acute drug
diuretic solution; 10 antihypertens the filtered hypotensive carefully;
mg/mL ive with fluid in the episodes, closely
injection pharmacologi kidney circulatory monitor BP
c effects and tubules, collapse. and vital
uses almost causing a Metabolic:Hy signs.
identical to profound povolemia, -Sudden
those of increase in dehydration, death from
ethacrynic the output of hyponatremia, cardiac arrest
acid. Exact urine hypokalemia, has been
mode of (diuresis). hypochloremia reported.
action not The onset of metabolic -Monitor BP
clearly action after alkalosis, during
defined; oral hypomagnese periods of
decreases administratio mia, diuresis and
renal n is within hypocalcemia through
vascular one hour, and (tetany), period of
resistance the diuresis hyperglycemia dosage
and may lasts about 6- , glycosuria, adjustment.
increase 8 hours. elevated BUN, -Observe
renal blood hyperuricemia older adults
flow. ;. closely
GI:Nausea, during period
vomiting, oral of brisk
and gastric diuresis.
burning, Sudden
anorexia, alteration in
diarrhea, fluid and
constipation, electrolyte
abdominal balance may
cramping, precipitate
acute significant
pancreatitis, adverse
jaundice.. reactions.
Hematologic: Report
Anemia, symptoms to
leukopenia, physician.
thrombocytop -Lab tests:
enic purpura; Obtain
agranulocytosi frequent
s blood count,
Skin:Pruritus, serum and
urticaria, urine
exfoliative electrolytes,
dermatitis, CO2, BUN,
purpura, blood sugar,
BodyWhole:I and uric acid
ncreased values during
perspiration; first few
paresthesias; months of
activation of therapy and
SLE, muscle periodically
spasms, thereafter.
weakness; Monitor for
thrombophlebi S&S of
ti hypokalemia
.
Dela Cruz, Kristine
Methrotrex Amethopt Anti- Induction: works used to treat . AzotemiaSevere. Monitor the
ate ertin, Rheumatic, 3.3 against folic certain types -Bleeding of the client taking
Folex, immunosu mg/m2/day acid of cancer of Stomach or Methotrexate
Trexall ppressant, orally or IM metabolism the breast, IntestinesSevere. for:
antimetabo (in which leads skin, head -Canker SoreSevere. -Abdominal
lite combinatio to the and neck, or -Decreased Blood pain, diarrhea or
n with inhibition of lung. Methotr PlateletsSevere. ulcerative
prednisone DNA exate is -Hole in the stomatitis.
60 mg/m2). synthesis also used to IntestineSevere. - Symptoms of
Maintenanc and cell treat severe -Infection caused by pulmonary
e (during production. psoriasis and BacteriaSevere. toxicity, which
remission): rheumatoid -Inflammation of the may manifest
15 mg/m2 arthritis. Gums and early as a dry
IM or orally MouthSevere. and
twice a nonproductive
week. cough.
Alternate
remission
dosing: 2.5
mg/kg IV
every 14
days.
Calcium Fluid and FLUID AND Children: Rapid-acting Relief of GI: Constipa
carbonate electrolyt ELECTROLY Not antacid with transient tion or Note number
e balance TIC recommend high symptoms of laxative and consistency
agent,repl BALANCE ed. neutralizing hyperacidity effect, acid of stools. If
acement AGENT; RE capacity and as in acid rebound, constipation is
solution, PLACEMEN relatively indigestion, nausea, a problem,
antacid T prolonged heartburn, eructation, f physician may
SOLUTION; duration of peptic atulence, vo prescribe
ANTACID action. esophagitis, miting, fecal alternate or
Decreases and hiatal concretions. combination
gastric hernia. Also Metabolic: therapy witha
acidity, used as Hypercalcem magnesium
thereby calcium ia with antacid or
inhibiting supplement alkalosis, advise patient
proteolytic when calcium metastatic to take a
action of intake may be calcinosis, laxative or stool
pepsin on inadequate hypercalciuri softener as
gastric and in a, necessary.
mucosa. treatment of hypomagnes
Also mild calcium emia, Lab tests:
increases deficiency hypophospha Determine
lower states. Control temia (when serum and
esophageal of phosphate urine calcium
sphincter hyperphosphat intake is weekly in
tone. emia in low). patients
Although chronic renal CNS: Mood receiving
classified as failure and mental prolonged
a (calcium changes. Ur
nonsystemic acetate). ogenital: Po therapy and in
antacid, a lyuria, renal patients with
slight to calculi. renal
moderate dysfunction.
alkalosis
usually Record
develops amelioration of
with symptoms of
prolonged hypocalcemia
therapy. Acid (see Signs &
rebound, Symptoms,
which may Appendix F)
follow even
low doses, is Observe for
thought to S&S of
be caused hypercalcemia
by release of in patients
gastrin receiving
triggered by frequent or
action of high doses, or
calcium in who have
small impaired renal
intestines. function (see
Appendix F).
digoxin lanoxin CARDIOVAS Digitalizin Widely used Rapid CNS: Fatigue, -Take apical
CULAR g Dose cardiac digitalization muscle pulse for 1 full
AGENT; CA glycoside and for weakness, min, noting
RDIAC Child: PO/I of Digitalis maintenance headache, rate, rhythm,
GLYCOSIDE; V <2 y, 40 lanata. Acts therapy in facial and quality
ANTIARRHY 60 by CHF, atrial neuralgia, before
THMIC mcg/kg; 2 increasing fibrillation, mental administering
10 y, 2040 the force atrial flutter, depression, drug.
mcg/kg; and velocity paroxysmal paresthesias, -Withold
>10 y, 10 of atrial hallucination medication and
15 mcg/kg myocardial tachycardia. s, confusion, notify physician
(1.52 mg) systolic drowsiness, if apical pulse
Neonate: P contraction agitation, falls below
O/IV 3050 (positive dizziness. ordered
mcg/kg inotropic CV: Arrhythm parameters
Premature effect). It ias, (e.g., <50 or
neonate: P also hypotension, 60/min in
O/IV 20 decreases AV block. adults and <60
mcg/kg conduction Special or 70/min in
Maintenan velocity Senses: Visu children).
ce Dose through the al -Be familiar
Child: PO/I atrioventricu disturbances. with patient's
V <2 y, lar node. GI: Anorexia, baseline data
7.59 Action is nausea, vomi (e.g., quality of
mcg/kg/d; 2 more prompt ting, peripheral
10 y, 67.5 and less diarrhea. pulses, blood
mcg/kg/d; prolonged pressure,
>10 y, than that of Other: Diaph clinical
0.1250.25 digitalis and oresis, symptoms,
mg/d digitoxin. recurrent serum
Neonate: 6 malaise, electrolytes,
7.5 dysphagia. creatinine
mcg/kg/d clearance) as a
Premature foundation for
neonate: 3. making
75 assessments.
mcg/kg/d -Lab tests:
Baseline and
periodic serum
digoxin,
potassium,
magnesium,
and calcium.
Draw blood
samples for
determining
plasma digoxin
levels at least 6
h after daily
dose and
preferably just
before next
scheduled daily
dose.
-Monitor for
S&S of drug
toxicity: In
children,
cardiac
arrhythmias are
usually reliable
signs of early
toxicity. Early
indicators in
adults
(anorexia,
nausea,
vomiting,
diarrhea, visual
disturbances)
are rarely initial
signs in
children.
-Monitor I&O
ratio during
digitalization,
particularly in
patients with
impaired renal
function. Also
monitor for
edema daily
and auscultate
chest for rales.
-Monitor serum
digoxin levels
closely during
concurrent
antibiotic
digoxin
therapy, which
can precipitate
toxicity
because of
altered
intestinal flora.
Observe
patients closely
when being
transferred
from one
preparation
(tablet, elixir, or
parenteral) to
another; when
tablet is
replaced by
elixir potential
for toxicity
increases
since 30% of
drug is
absorbed.
fluconazol diflucan Antiinfectiv Oropharyng Fungistatic; CNS: Heada -Monitor for
e e, eal may also be che. GI: Nau allergic
antibiotic, Candidiasis fungicidal sea, response.
antifungal Child: PO/IV depending vomiting, Patients allergic
36 on abdominal to other azole
mg/kg/d concentratio pain, antifungals may
Esophageal n. Interferes diarrhea, be allergic to
Candidiasis with increase in fluconazole.
Child: PO/IV formation of AST in -Lab tests:
36 ergosterol, patients with Monitor BUN,
mg/kg/d the principal cryptococcal serum
Systemic sterol in the meningitis creatinine, and
Candidiasis fungal cell and liver function.
Child: PO/IV membrane AIDS. Skin: -Note: Drug
36 that, when Rash. may cause
mg/kg/d depleted, elevations of
Cryptococc interrupts the following
al membrane laboratory
Meningitis function. serum values:
Child: PO/IV ALT, AST,
36 alkaline
mg/kg/d phosphatase,
bilirubin.
-Monitor for
S&S of
hepatotoxicity.
Digitalis Digoxin Antiarrhyth Force and Rapid Diarrhea; -Take apical
Glycosides digitoxin mic velocity of digitalization dizziness; pulse for 1 full
cardiotonic myocardial and for headache; min, noting
contraction maintenance nausea. rate, rhythm,
are therapy in and quality
increased CHF, atrial before
(positive fibrillation, administering
inotropic atrial flutter, drug.
effect). This paroxysmal -Withold
effect is atrial medication and
thought to tachycardia. notify physician
result from if apical pulse
inhibition of falls below
movement ordered
of sodium parameters
and (e.g., <50 or
potassium 60/min in
ions across adults and <60
myocardial or 70/min in
cell children).
membranes -Be familiar
by with patient's
complexing baseline data
with (e.g., quality of
adenosine peripheral
triphosphata pulses, blood
se. As a pressure,
result, there clinical
is symptoms,
enhancemen serum
t of calcium electrolytes,
influx and an creatinine
augmented clearance) as a
release of foundation for
free calcium making
ions within assessments.
the Lab tests:
myocardial Baseline and
cells to periodic serum
subsequentl digoxin,
y potentiate potassium,
the activity magnesium,
of the and calcium.
contractile Draw blood
muscle samples for
fibers of the determining
heart. plasma digoxin
levels at least 6
h after daily
dose and
preferably just
before next
scheduled daily
dose.
`
Mannitol osmitrol Electrolyte Acute In large To promote CNS: Heada Take care to
and water Kidney doses, diuresis in che, tremor, avoid
balance Failure increases prevention convulsions, extravasation.
agent, Child: IV rate of and treatment dizziness, Observe
osmotic Test electrolyte of oliguric transient injection site for
diuretic Dose 200 excretion by phase of acute muscle signs of
mg/kg the kidney, kidney failure rigidity. CV: inflammation or
(max: 12.5 particularly following Edema, CHF, edema
g) over 35 sodium, cardiovascular angina-like -Lab tests:
min Positiv chloride, and surgery, pain, Monitor closely
e potassium. severe hypotension, serum and
Response traumatic hypertension urine
Urine flow injury, surgery , electrolytes and
of 1 in presence of thrombophle kidney function
mL/kg/h for severe bitis. Eye: Bl during therapy.
12 jaundice, urred Measure I&O
h Mainten hemolytic vision. GI: Dr accurately and
ance 0.25 transfusion y mouth, record to
0.5 g/kg reaction. Also nausea, achieve proper
q46 h used to reduce vomiting. Ur fluid balance.
elevated ogenital: M -Monitor vital
intraocular arked signs closely.
(IOP) and diuresis, Report
intracranial urinary significant
pressure (ICP), retention, changes in BP
to measure nephrosis, and signs of
glomerular uricosuria. M CHF.
filtration rate etabolic: Fl -Monitor for
(GFR), to uid and possible
promote electrolyte indications of
excretion of imbalance, e fluid and
toxic specially hyp electrolyte
substances, to onatremia; imbalance
relieve dehydration, (e.g., thirst,
symptoms of acidosis. Oth muscle cramps
pulmonary er: With or weakness,
edema, and as extravasatio paresthesias,
irrigating n (local and signs of
solution in edema, skin CHF).
transurethral necrosis; Be alert to the
prostatic chills, fever, possibility that
reaction to allergic a rebound
minimize reactions). increase in ICP
hemolytic sometimes
effects of occurs about 12
water. h after drug
Commercially administration.
available in Patient may
combination complain of
with sorbitol headache or
for urogenital confusion.
irrigation. Take accurate
daily weight.
streptokin Kabikinas BLOOD Children: Derivative of Acute Body as a -Lab tests:
ase e, Strepta FORMERS, the beta- extensive Whole: Aller Discontinue
Not
se COAGULAT hemolytic deep venous gic heparin and
recommend
ORS, AND streptococci. thrombosis, reactions (br obtain baseline
ANTICOAG ed. Promotes acute arterial onchospasm, control levels
ULANTS; T thrombolysis thrombosis or periorbital for TT, aPTT,
HROMBOLY by activating embolism, swelling, PT, INR, Hct,
TIC the acute angioneuroti and platelet
ENZYME conversion pulmonary c count prior to
of embolus, edema, anap treatment.
plasminogen coronary hylaxis); Treatment is
to plasmin, artery urticaria, delayed until TT
the enzyme thrombosis, itching, and aPTT are
that MI, and headache, less than 2
degrades arteriovenous musculoskel times the
fibrin, cannula etal pain, normal control
fibrinogen, occlusion. flushing, level. During
and other nausea, treatment with
procoagulant pyrexia.Hem SK, TT is
proteins into atologic: Phl generally kept
soluble ebitis, bleedi at about 2
fragments. ng or oozing times or more
Decreases at sites of baseline value
blood and percutaneou and checked
plasma s q34h.
viscosity and trauma; prol -Protect patient
erythrocyte onged from invasive
aggregation systemic procedures: IM
tendency, hypocoagula injections are
thus bility; contraindicated
increasing spontaneous . -Also prevent
perfusion of bleeding (GI, undue
collateral urogenital, manipulation
blood retroperitone during
vessels. al). CV: Unst thrombolytic
able blood therapy to
pressure; prevent
reperfusion bruising.
atrial Spontaneous
or ventricular bleeding occurs
dysrhythmia about twice as
s. often with SK as
with heparin.
-Monitor for
excessive
bleeding
q15min for the
first hour of
therapy,
q30min for
second to
eighth hour,
then q8h.
Be aware that
patient is at
risk for
postthrombolyti
c bleeding for
24 d after
intracoronary
SK treatment.
Continue
monitoring vital
signs until
laboratory tests
confirm
anticoagulant
control. Report
signs of
potential
serious
bleeding; gum
bleeding,
epistaxis,
hematoma,
spontaneous
ecchymoses,
oozing at
catheter site,
increased
pulse, pain
from internal
bleeding. SK
infusion should
be interrupted,
then resumed
when bleeding
stops.
Report
promptly
symptoms of a
major allergic
reaction;
therapy will be
discontinued
and emergency
treatment
instituted.
Minor
symptoms
(e.g., itching,
nausea)
respond to
concurrent
antihistamine
or
corticosteroid
treatment or
both without
interruption of
SK
administration.
Check cardiac
monitor
frequently. Be
alert to
changes in
cardiac rhythm,
especially
during
intracoronary
instillation.
Dysrhythmias
signal need to
stop therapy at
once.
Monitor BP. Mild
changes can be
expected, but
report
substantial
changes
(greater than
25 mm Hg).
Therapy may
be
discontinued.